Dna X (SONM) Receivables - Net (2018 - 2026)

Dna X has reported Receivables - Net for 9 years, with the latest figure at $57000.0 in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 98.82% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2026 stood at $57000.0 (down 98.82% YoY), and the FY2024 full-year result was $4.3 million, down 82.85% from the prior year.
• Receivables - Net for Q1 2026 stood at $57000.0, down from $3.5 million in the prior quarter.
• The five-year high for Receivables - Net was $30.3 million in Q3 2023, with the low at $57000.0 in Q1 2026.
• Historically, Receivables - Net has averaged $12.5 million across 5 years, with a median of $7.8 million in 2024.
• Annual changes were most pronounced in 2022 — Receivables - Net soared 384.1% — and 2026, when it plunged 98.82%.
• Dna X's Receivables - Net stood at $22.4 million in 2022, then gained by 12.8% to $25.3 million in 2023, then plunged by 82.85% to $4.3 million in 2024, then dropped by 19.38% to $3.5 million in 2025, then tumbled by 98.37% to $57000.0 in 2026.
• The last three Receivables - Net figures came in at $57000.0 (Q1 2026), $3.5 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.